MarketsandMarkets projects the global peritoneal dialysis market to rise from ~$10.04B in 2026 to $14.16B by 2031, implying 6.0% CAGR (2026–2031). Growth is attributed to rising elderly/CKD prevalence and increased home dialysis adoption, with home care (highest CAGR 6.3%) and Asia Pacific (7.6% CAGR) highlighted as key growth pockets.
The equity implication is less about aggregate market growth and more about modality mix. A home-based dialysis shift generally lowers servicing intensity per patient over time, which is constructive for providers that can capture recurring consumables and training economics, but it pressures legacy in-center networks that rely on higher touch labor and facility utilization. That makes DVA a relative winner versus Fresenius Medical Care over a 6-18 month horizon if home penetration continues to grind higher, while suppliers of disposable consumables should see steadier revenue quality than capital-equipment vendors. The second-order effect is margin structure: recurring bag/solution usage creates a more annuity-like stream, but only if reimbursement and logistics hold. In the near term, the market may overreact to the TAM headline because the actual equity translation depends on patient onboarding rates, infection outcomes, and payer mix rather than demand awareness. For BDX and UTMD, the cleanest read is selective upside to niche disposables, but this is unlikely to move consolidated earnings without evidence of share gain or pricing power. Contrarian view: the consensus is likely overestimating how quickly Asia Pac growth becomes monetizable for U.S.-listed names. The biggest beneficiaries may be regional manufacturers and service operators, while global brands face distribution and reimbursement friction. The key falsifier is any evidence that home dialysis adoption stalls, reimbursement tightens, or infection/technique-failure rates rise enough to push patients back into center-based care.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
